In vivo effects of cell seeding technique in an ex vivo regional gene therapy model for bone regeneration

被引:0
|
作者
Bell, Jennifer A. [1 ]
Mayfield, Cory K. [1 ]
Collon, Kevin [1 ]
Chang, Stephanie [1 ]
Gallo, Matthew C. [1 ]
Lechtholz-Zey, Elizabeth [1 ]
Ayad, Mina [1 ]
Sugiyam, Osamu [1 ]
Tang, Amy H. [1 ]
Park, Sang-Hyun [2 ]
Lieberman, Jay R. [1 ]
机构
[1] Keck Sch Med USC, Dept Orthopaed Surg, 1500 San Pablo St,Suite 2000, Los Angeles, CA 90033 USA
[2] J Vernon Luck Orthopaed Res Ctr, Orthopaed Inst Children, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
orthopedics; bone healing; bone morphogenetic protein-2; bone tissue engineering; cell density; cell dose; dynamic cell seeding; static cell seeding; BASIC SCIENCE; SCAFFOLDS; SUBSTITUTES; PERFUSION; ENHANCE; REPAIR;
D O I
10.1002/jbm.a.37718
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
When delivering cells on a scaffold to treat a bone defect, the cell seeding technique determines the number and distribution of cells within a scaffold, however the optimal technique has not been established. This study investigated if human adipose-derived stem cells (ASCs) transduced with a lentiviral vector to overexpress bone morphogenetic protein 2 (BMP-2) and loaded on a scaffold using dynamic orbital shaker could reduce the total cell dose required to heal a critical sized bone defect when compared with static seeding. Human ASCs were loaded onto a collagen/biphasic ceramic scaffold using static loading and dynamic orbital shaker techniques, compared with our labs standard loading technique, and implanted into femoral defects of nude rats. Both a low dose and standard dose of transduced cells were evaluated. Outcomes investigated included BMP-2 production, radiographic healing, micro-computerized tomography, histologic assessment, and biomechanical torsional testing. BMP-2 production was higher in the orbital shaker cohort compared with the static seeding cohort. No statistically significant differences were noted in radiographic, histomorphometric, and biomechanical outcomes between the low-dose static and dynamic seeding groups, however the standard-dose static seeding cohort had superior biomechanical properties. The standard-dose 5 million cell dose standard loading cohort had superior maximum torque and torsional stiffness on biomechanical testing. The use of orbital shaker technique was labor intensive and did not provide equivalent biomechanical results with the use of fewer cells.
引用
收藏
页码:1688 / 1698
页数:11
相关论文
共 50 条
  • [41] Effects of peptide therapy on ex vivo T-cell responses
    Marcotte, GV
    Braun, CM
    Norman, PS
    Nicodemus, CF
    Kagey-Sobotka, A
    Lichtenstein, LM
    Essayan, DW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (04) : 506 - 513
  • [42] Cell-Based Ex Vivo Gene Therapy with BMP2 Gene Transduced Dermal Fibroblasts To Accelerate Bone Healing in Equine Model
    Ishihara, Akikazu
    Zekas, Lisa J.
    Weisbrode, Steven E.
    Bertone, Alicia L.
    MOLECULAR THERAPY, 2009, 17 : S268 - S269
  • [43] Quality control for ex vivo cell therapy
    Kielpinski, G
    Kehinde, O
    Kaplan, BM
    Bonn, T
    Buxton, D
    Wescott, MZ
    Arangio, A
    Duguid, EJ
    Thyne, C
    DuMoulin, GC
    BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS, 1997, 10 (01): : 34 - &
  • [44] Ex vivo gene therapy of hemophilia A and B using bone marrow stromal cells in a canine model.
    Hurwitz, DR
    Cherington, V
    Rubin, H
    Wang, T
    Sobolewski, J
    Galanopoulos, T
    Gaffney, A
    McGrath, CA
    Levine, PH
    Greenberger, JS
    Chiang, GG
    BLOOD, 1998, 92 (10) : 384B - 384B
  • [45] Ex vivo gene therapy of hemophilia A and B using bone marrow stromal cells in a canine model.
    Hurwitz, DR
    Chiang, GG
    Cherington, V
    Rubin, H
    Wang, T
    Sobolewski, J
    Galanopoulos, T
    Natale, A
    McGrath, CA
    Bizinkauskas, CB
    Merrill, W
    Hansen, M
    Levine, PH
    Greenberger, JS
    BLOOD, 1997, 90 (10) : 1052 - 1052
  • [46] THE EFFECTS OF CONTROLLED LIVER-REGENERATION ON HEPATOCYTE TRANSPLANTATION IN THE MOUSE - IMPLICATIONS FOR EX-VIVO GENE-THERAPY
    VRANCKENPEETERS, MJ
    LIEBER, A
    PERKINS, J
    KAY, MA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 386 - 386
  • [47] In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification
    Ebrahimi, Pouya
    Davoudi, Elham
    Sadeghian, Razieh
    Zadeh, Amin Zaki
    Razmi, Emran
    Heidari, Reza
    Morowvat, Mohammad Hossein
    Sadeghian, Issa
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, : 7501 - 7530
  • [48] In vivo regeneration of small-diameter arteries using a novel tissue-engineered biodegradable vascular graft without ex vivo cell seeding
    Yokota, Takenori
    Ichikawa, Hajime
    Matsumiya, Gorou
    Torikai, Kei
    Kitabayasi, Katsukiyo
    Hirakawa, Kouichirou
    Sawa, Yoshiki
    CIRCULATION, 2006, 114 (18) : 34 - 34
  • [49] A single epidermal stem cell strategy for safe ex vivo gene therapy
    Lathion, Stephanie Droz-Georget
    Rochat, Ariane
    Knott, Graham
    Recchia, Alessandra
    Martinet, Danielle
    Benmohammed, Sara
    Grasset, Nicolas
    Zaffalon, Andrea
    Schmutz, Nathalie Besuchet
    Savioz-Dayer, Emmanuelle
    Beckmann, Jacques Samuel
    Rougemont, Jacques
    Mavilio, Fulvio
    Barrandon, Yann
    EMBO MOLECULAR MEDICINE, 2015, 7 (04) : 380 - 393
  • [50] Prospects for insulin delivery by ex-vivo somatic cell gene therapy
    Bailey, CJ
    Davies, EL
    Docherty, K
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (01): : 244 - 249